[go: up one dir, main page]

BG31074A3 - Method for obtaining of 1- oxadethiacefalosporine - Google Patents

Method for obtaining of 1- oxadethiacefalosporine

Info

Publication number
BG31074A3
BG31074A3 BG035796A BG3579677A BG31074A3 BG 31074 A3 BG31074 A3 BG 31074A3 BG 035796 A BG035796 A BG 035796A BG 3579677 A BG3579677 A BG 3579677A BG 31074 A3 BG31074 A3 BG 31074A3
Authority
BG
Bulgaria
Prior art keywords
oxadethiacefalosporine
obtaining
oxadithiacephalosporins
proven
formulated
Prior art date
Application number
BG035796A
Other languages
Bulgarian (bg)
English (en)
Inventor
Masayaki Narisada
Wataru Nagata
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG31074A3 publication Critical patent/BG31074A3/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG035796A 1976-03-25 1977-03-24 Method for obtaining of 1- oxadethiacefalosporine BG31074A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
BG31074A3 true BG31074A3 (en) 1981-10-15

Family

ID=26372085

Family Applications (1)

Application Number Title Priority Date Filing Date
BG035796A BG31074A3 (en) 1976-03-25 1977-03-24 Method for obtaining of 1- oxadethiacefalosporine

Country Status (19)

Country Link
AR (1) AR224606A1 (no)
BG (1) BG31074A3 (no)
CY (1) CY1158A (no)
DD (1) DD129792A5 (no)
DE (1) DE2713370C2 (no)
DK (1) DK161331C (no)
ES (5) ES457174A1 (no)
GR (1) GR61146B (no)
HK (1) HK46882A (no)
HU (1) HU172720B (no)
IE (1) IE44794B1 (no)
IL (1) IL51743A (no)
MX (1) MX4348E (no)
NO (2) NO158505C (no)
NZ (1) NZ183687A (no)
PT (1) PT66346B (no)
RO (2) RO78228A (no)
SE (1) SE443143B (no)
YU (2) YU44039B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU514377B2 (en) * 1977-02-15 1981-02-05 Shionogi & Co., Ltd. l-OXADETHIACEPHAM COMPOUNDS
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US3962232A (en) * 1973-11-05 1976-06-08 Eli Lilly And Company 7-methoxycephalosporins
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
DK131277A (da) 1977-09-26
IE44794B1 (en) 1982-04-07
NO158505B (no) 1988-06-13
MX4348E (es) 1982-04-05
DK161331B (da) 1991-06-24
HU172720B (hu) 1978-11-28
DD129792A5 (de) 1978-02-08
YU173883A (en) 1983-12-31
ES469284A1 (es) 1978-11-16
YU44038B (en) 1990-02-28
DE2713370C2 (de) 1994-04-21
SE7703325L (sv) 1977-09-26
ES469285A1 (es) 1979-09-16
DK161331C (da) 1991-12-09
YU44039B (en) 1990-02-28
ES469286A1 (es) 1979-09-16
DE2713370A1 (de) 1977-09-29
NO158505C (no) 1988-09-21
NO771023L (no) 1977-09-27
RO71742A (ro) 1982-02-26
IE44794L (en) 1977-09-25
NZ183687A (en) 1979-01-11
SE443143B (sv) 1986-02-17
IL51743A (en) 1980-10-26
GR61146B (en) 1978-09-27
AR224606A1 (es) 1981-12-30
ES457174A1 (es) 1978-08-16
CY1158A (en) 1983-01-28
RO78228A (ro) 1982-02-01
NO862107L (no) 1977-09-27
ES469287A1 (es) 1979-09-16
HK46882A (en) 1982-11-19
YU173783A (en) 1983-12-31
PT66346A (en) 1977-04-01
PT66346B (en) 1978-08-16

Similar Documents

Publication Publication Date Title
BG28065A4 (en) Method of obtaining of 2-phenyl-3-aroylbenzothiophenes
BG31497A3 (en) Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid
BG31645A3 (en) Method for obtaining of phenetanolamine
BG31225A3 (en) Method for obtaining of acilanilid derivatives
BG34338A3 (en) Method for obtaining thiadiazolylcephalosporines
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
BG33294A3 (en) Method for obtaining the derivatives of 4- dezacetyl- vincaledcoblactine c- 3- carboxyhydrazid
BG31491A3 (en) Method for obtaining of phenetanolamines 7
BG28068A3 (en) Method of obtaining of 3-chlorcephalosporines
BG28072A4 (en) Method of obtaining of 1-substitvated canamyzine derivatives
BG31073A3 (en) Method for obtaining of 1, 5- substituated- 2- pyrolidine
BG34038A3 (en) A method of obtaining 7- substituted aminoacetamidooxadetiacephalosprorines
BG30021A3 (en) Method for obtaining of imidazoisohinolin- dion
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG28574A3 (en) Method of obtaining of 4- diphenylmethylene- 1- hydroxybensylpiperidin
BG31503A3 (en) Method for obtaining the derivatives of octahjdroindolhinolzine
BG32117A4 (en) Method for obtaining of oleandomicine
BG28845A3 (en) Method of obtaining of n- alkyldiphenylamines
BG28415A4 (en) Method of obtaining of 9-hydroxyoctahydrobenzo (c) hynolines
BG33284A3 (en) Method for obtaining of pyridazinylhydrazon
BG28066A3 (en) Method of obtaining of pyridobenzodiazepinones
BG31947A3 (en) Method for obtaining of acetidine derivatives
BG35032A3 (en) Method for preparing 1, 1, 2- triphenylpropene derivatives
BG36347A3 (en) Method for preparing thienopyridinon derivatives
BG31074A3 (en) Method for obtaining of 1- oxadethiacefalosporine